3650 results for «397»
3650 results
Featured cases - TAVI in aortic regurgitation
26 Nov 2024 – From PCR London Valves 2024
Delve into this session featuring selected clinical cases from PCR London Valves 2024, focusing on the use of TAVI to address aortic regurgitation. Gain insights into the management of pure native aortic regurgitation in surgically unfit patients, the treatment of aortic regurgitation in patients with left...
Featured research - Aortic valve (Part 10)
26 Nov 2024 – From PCR London Valves 2024
Explore the latest research and insights in the field of aortic valve interventions through this featured research session. Discover cutting-edge studies on topics ranging from one-year outcomes after TAVI in different valve types to the impact of frailty and mobility on post-TAVI outcomes, and much more....
Featured cases - Tricuspid TEER
26 Nov 2024 – From PCR London Valves 2024
Delve into this session featuring selected clinical cases from PCR London Valves 2024, focusing on the use of transcatheter edge-to-edge repair (TEER) for the treatment of tricuspid regurgitation. Explore innovative techniques such as the use of the Pascal device in a patient with dextrocardia, the combination...
Featured cases - When the cardiologist meets the surgeon
26 Nov 2024 – From PCR London Valves 2024
Dive into a collection of captivating clinical cases where the cardiologist and surgeon collaborate to tackle complex cardiovascular challenges. From direct vision TAVI implantation during left ventricular assist device surgery to managing iatrogenic annulus rupture during TAVR, this session offers invaluable insights into the art of...
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.
Author
IMPELLA supported PCI via a single access sheath - Introduction and rapid adoption: the Power of Social Media
22 Dec 2020
This manuscript examines Impella single access technique, which provides a case example of the central role social media can play in the introduction of a new interventional approach.
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation
05 Sep 2023
Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.
Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...
Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)
08 Apr 2024
Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.
Author
